News
Although cures for age-related macular degeneration are elusive, the case for prevention through nutrition looks strong and ...
NIH scientists explore a new multi-graft retinal surgery technique to advance cell therapy for treating dry age-related ...
Steven T. Reed, O.D., discusses age-related macular degeneration (AMD), the leading cause of severe vision loss in adults ...
LUCIA pivotal Phase 3 trial continues rapid enrollment pace with 60% of patients randomized; enrollment completion expected in 3Q 2025 – – Topline 56-week data for LUGANO expected in mid-2026 with ...
Key trends include advanced multicolor laser adoption and increased outpatient treatments. Challenges include reimbursement issues and competition from alternative therapies. Leading players like ...
A new study from the National Eye Institute has found that eating foods high in dietary nitrates—mainly from vegetables—may ...
Numerous autoimmune diseases are associated with the development of age-related macular degeneration (AMD), according to ...
Lupin has signed an agreement with SteinCares for the commercialization of biosimilar ranibizumab in Latin America, excluding ...
1d
News-Medical.Net on MSNAffordable HIV drug shows promise in improving vision for diabetic eye diseaseAn inexpensive, long-approved HIV drug can improve vision in patients with a blinding complication of diabetes more ...
6d
News-Medical.Net on MSNPowerful new toolkit targets vision loss in advanced retinal degenerationInherited retinal degenerations (IRDs) are a group of genetic disorders that lead to progressive vision loss as the ...
Lupin will manufacture biosimilar ranibizumab while SteinCares handles registration and marketing in Latin America, excluding ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results